Abo Hemolytic Disease of the Newborn: A Unique Constellation of Findings in Siblings and Review of Protective Mechanisms in the Fetal-Maternal System

American Journal of Perinatology

Volumn , Issue , 1999, Pages 391-398

  Waldron, Peter ^a   de Alarcon, Pedro ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Dermal hematopoiesis; intravascular hemolysis; mechanisms of hemolysis; thrombocytopenia

Indexed keywords

ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CASE REPORT; HEMATOPOIESIS; HEMOGLOBINURIA; HEPATOSPLENOMEGALY; HUMAN; INFANT; INTRAVASCULAR HEMOLYSIS; MOTHER FETUS RELATIONSHIP; NEWBORN HEMOLYTIC DISEASE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; ERYTHROBLASTOSIS, FETAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; NUCLEAR FAMILY; PREGNANCY; PROGNOSIS;

EID: 0033498459     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-1999-6820     Document Type: Article

References (51)

1. Oski FA, Naiman JL. Hematologic Problems in the Newborn, 3rd ed. Philadelphia: WB Saunders; 1982: 283-346
2. Kirkman HN, Jr. Further evidence of racial difference in frequency of ABO hemolytic disease. J Pediatr 1977; 90: 717-721
3. Dufour DR, Monoghan WP. ABO hemolytic disease of the newborn: A retrospective analysis of 254 cases. Am J Clin Pathol 1980; 73: 369-373
4. Ukita M, Takahashi A, Nunotani T, Kihana T, Watanabe S, Yamada N. IgG subclasses of anti-A and anti B antibodies bound to the cord red cells in ABO incompatible pregnancies. Vox Sang 1989; 56: 181-186
5. Desjardins L, Blajchman MA, Chintu C, Gent M, Zipursky A. The spectrum of ABO hemolytic disease of the newborn infant. J Pediatr 1979; 95: 447-449
6. Ozolek JA, Watchko JF, Mimouni F. Prevalence and lack of clinical significance of blood group incompatibility in mothers with blood type A or B. J Pediatr 1994; 125: 87-91
7. Peevy KJ, Wiseman HJ. ABO hemolytic disease of the newborn: Evaluation of management and identification of racial and antigenic factors. Pediatrics 1978; 61: 475-478
8. Osborn LM, Lenarsky C, Oakes RC, Reiff MI. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility. Pediatrics 1984; 74: 371-374
9. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell Scientific Publications; 1993: 590
10. Bowman JM. Immune hemolytic disease. In: Nathan DG, Orkin SH, eds. Nathan and Oski's Hematology of Infancy and Childhood. 5th ed. Philadelphia: WB Saunders; 1998: 53-78
11. Sherer DM, Abramowicz JS, Ryan RM, Sheils LA, Blumberg N, Woods JR. Severe fetal hydrops resulting from ABO incompatibility. Obstet Gynecol 1991; 78: 897-899
12. Stiller RJ, Herzlinger R, Siegel S, Whetham JC. Fetal ascites associated with ABO incompatibility: Case report and review of the literature. Am J Obstet Gynecol 1996; 175: 1371-1372
13. Gold ER, Butler NR. ABO Haemolytic disease of the newborn. Baltimore: Williams and Wilkins; 1972
14. Gilja BK, Shah VP. Hydrops fetalis due to ABO incompatibility. Clin Pediatr 1988; 27: 210-212
15. Miller DF, Petrie SJ. Fetal erythroblastosis fetalis secondary to ABO incompatibility. Obstet Gynecol 1963; 22: 773-777
16. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell Scientific Publications; 1993: 584
17. Fleer A, van Schaik MLJ, von dem Borne AE, Engelfreit CP. Destruction of sensitized erythrocytes by human monocytes in vitro: Effects of cytochalasinb, hydrocortisone and colchicine. Scand J Immunol 1978; 8: 515-524
18. Engelfreit CP, Overbeeke MA, Dooren MC, Ouwehand WH, von dem Borne AE. Bioassays to determine the clinical significance of red cell alloanti-bodies based on Fc receptor-induced destruction of red cells sensitized by IgG. Transfusion 1994; 34: 617-626
19. Wiener E, Jolliffe VM, Scott HC, et al. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes. Immunology 1988; 65: 159-163
20. 3 anti-D. Vox Sang 1989; 57: 150-151
21. Merlob P, Litwin A, Lazar L, Zaizov R. Neonatal ABO incompatibility complicated by hemoglobinuria and acute renal failure. Clin Pediatr 1990; 29: 219-222
22. Angella JJ, Prieto EN, Fogel BJ. Hemoglobinuria associated with hemolytic disease of the newborn. J Pediatr 1967; 71: 550-553
23. Schmidt PJ, Holland PV. Pathogenesis of the acute renal failure associated with incompatible transfusion. Lancet 1967 1169-1172
24. Boineau FG, Hallock JA. Two examples of severe fetal disease due to ABO incompatibility. Clin Pediatr 1967; 10: 180-182
25. Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986; 108: 749-755
26. George D, Bussel JB. Neonatal thrombocytopenia. Semin Thromb Hemost 1995; 21: 276-293
27. Bowden JB, Hebert AA, Rapini RR. Dermal hematopoiesis in neonates: Report of five cases. J Am Acad Dermatol 1989; 20: 1104-1110
28. Hebert AA, Esterly NB, Gardner TH. Dermal erythropoiesis in Rh hemolytic disease of the newborn. J Pediatr 1985; 107: 799-801
29. Argyle JC, Zone JJ. Dermal erythropoiesis in a neonate. Arch Dermatol 1981; 117: 492-494
30. Schwartz JL, Maniscalo WM, Lane AT, Currao WJ. Twin transfusion syndrome causing cutaneous erythropoiesis. Pediatrics 1984; 74: 527-529
31. Baselga E, Drolet BA, Esterly, NB. Purpura in infants and children. J Am Acad Dermatol 1997; 37: 673-705
32. Brouwers HA, Overbeeke MA, van Ertbruggen I, et al. What is the best predictor of the severity of ABO-haemolytic disease of the newborn? Lancet 1988; 2: 641-644
33. Clausen H, Hakamori S-i. ABH and related histo blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang 1989; 56: 1-20
34. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell Scientific Publications; 1993: 579
35. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell Scientific Publications; 1993: 132
36. Brouwers HA, Overbeeke MA, Huiskes E, Bos MJ, Ouwehand WH, Engelfreit CP. Complement is not activated in ABO-haemolytic disease of the newborn. Br J Haematol 1988; 68: 363-366
37. Pujol M, Ribera A, Abella E, Natal A, Bel J, Coroleu W. Complement is not activated in ABO-haemolytic disease of the newborn: Two exceptions. Vox Sang 1991; 61: 76
38. Hakamori S. Blood group ABH and Ii antigens of human erythrocytes: Chemistry, polymorphism, and their developmental change. Semin Hematol 1981; 18: 39-62
39. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell Scientific Publications; 1993: 155
40. Sylvestre D Clynes R, Ma M, Warren H, Carroll MC, Ravetch JV. Immunoglobulin G-mediated inflammatory responses develop normally in complement deficient mice. J Exp Med 1996; 184: 2385-2392
41. Clynes R, Ravetch JV. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 1995; 3: 21-26
42. von dem Borne AE, Beckers D, Engelfriet CP. Mechanisms of red cell destruction mediated by non-complement binding IgG antibodies: The essential role in vivo of the Fc part of IgG. Br J Haematol 1977; 36: 485-493
43. Dooren MC, Engelfreit CP. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus. Vox Sang 1993; 65: 59-61
44. van der Meulen FW, van der Hart M, Fleer A, von dem Borne AE, Engelfriet CP, van Loghem JJ. The role of adherence to human mononuclear phagocytes in the destruction of red cells sensitized with non-complement binding IgG antibodies. Br J Haematol 1978; 38: 541-549
45. Dooren MC, Kuijpers RW, Joekes EC, et al. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR). Lancet 1992; 339: 1067-1070
46. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PA. A single amino acid in the second Ig-like domain of the human Fc7 receptor II is critical for human IgG2 binding. J Immunol 1991; 147: 1338-1343
47. Reilly AF, Norris CF, Surrey S, et al. Genetic diversity in human Fc receptor II for immunoglobulin G: Fey receptor IIA ligand-binding polymorphism. Clin Diagn Lab Immunol 1994; 1: 640-644
48. Salmon JE, Millard S, Schachter LA, et al. Fcγ RIIA al-leles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97: 1348-1354
49. Gottval T, Hilden J-O. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants. Acta Obstet Gynecol Scand 1997; 76: 733-738
50. Greenwell P. Blood group antigens: molecules seeking a function? Glycoconjugate J 1997; 14: 159-173
51. Madlon-Kay DJ. Identifying ABO incompatibility in newborns: Selective testing vs automatic testing. J Fam Pract 1992; 35: 278-280